David Mandel
CEO
Cavidi
Sweden
Biography
David Mandel, is the CEO of Caividi. After 20 years of increasingly senior Sales & Marketing, Treasury, Finance & Administration roles in a range of multinational companies in England, Australia and USA, he became the CEO of a $100 million Australian subsidiary of Riverwood International Inc. In the past decade he has worked as a consultant, primarily working with start-up companies, some of which were biotech companies. He is a presently a Director of Narhex Life Sciences Ltd and Cavidi AB. He has a BSc in Chemistry from the University of Sussex, and he is also a Chartered Management Accountant (CMA), a senior member of the Finance & Treasury Association of Australia and a Member of the Australian Institute of Company Directors (MAICD)
Research Interest
Sales & Marketing